Streetbeat News

Stock Prices

GILD

RCUS

Gilead Sciences and Arcus Biosciences released positive data from their Phase 2 EDGE-Gastric and ARC-9 studies, showing promising results in gastric and colorectal cancers. Despite recent setbacks in bladder cancer studies, these new findings could bolster investor confidence.

Portfolio Pulse from Vandana Singh

June 03, 2024 | 4:35 pm

BDVG

NUE

SLX

Nucor Corporation (NYSE:NUE) has announced the acquisition of Rytec Corporation for $565 million in an all-cash transaction. This move is part of Nucor's strategy to diversify beyond steelmaking into related downstream businesses. The acquisition is expected to create cross-selling opportunities and expand Nucor's product portfolio. Nucor shares are trading lower following the announcement.

Portfolio Pulse from Lekha Gupta

June 03, 2024 | 4:34 pm

FCEL

FuelCell Energy, Inc. (NASDAQ:FCEL) shares are trading higher, up more than 12% over the past five days. The company announced a significant agreement with Gyeonggi Green Energy Co., Ltd. to supply 42 upgraded fuel cell modules and a seven-year service agreement, expected to generate $160 million in revenue. Additionally, 22.63% of available shares are being sold short, which can lead to large price movements. FuelCell Energy is set to report its second-quarter financial results on June 10, with analysts expecting losses of 8 cents per share and quarterly revenue of $21.351 million. The stock has an average 1-year price target of $1.75, indicating a potential upside of 79.4%.

Portfolio Pulse from Erica Kollmann

June 03, 2024 | 4:31 pm

AYRO

DOGZ

FEDU

GME

HZO

JFBR

PIK

SLNA

SPWH

VNCE

The article highlights significant intraday movements in consumer discretionary stocks on Monday. Notable gainers include Four Seasons Education (FEDU), GameStop (GME), Dogness (DOGZ), MarineMax (HZO), Jeffs Brands (JFBR), and Sportsman's Warehouse (SPWH). On the losing side, Smart Share Global (EM), AYRO (AYRO), Kidpik (PIK), Selina Hospitality (SLNA), Vince Holding (VNCE), and 17 Education & Technology (YQ) saw declines.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 4:31 pm

CCM

CNSP

GPCR

GRTX

The article highlights significant intraday movements in health care stocks on Monday. Structure Therapeutics (GPCR) saw a 71% increase, while Concord Medical Services (CCM) rose by 55.96%. On the downside, CNS Pharma (CNSP) and Galera Therapeutics (GRTX) experienced declines of 32.2% and 31.67%, respectively.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 4:31 pm

AMBI

EFSH

IPDN

IPW

NNE

SAIC

SMXT

SOAR

SRCL

TISI

YGMZ

The article highlights the intraday movements of various industrial stocks on Monday. Notable gainers include MingZhu Logistics Holdings, Ambipar Emergency, iPower, SolarMax Technology, Stericycle, and Professional Diversity. On the losing side, 1847 Holdings, Team, Wheels Up Experience, Nano Nuclear Energy, Science Applications International, and Volato Group saw significant declines.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 4:31 pm

ASTI

CAMP

COHR

FOXO

LSCC

TACT

The article highlights the intraday movements of various information technology stocks on Monday. Notable gainers include Ascent Solar Technologies, Coherent, and Transact Technologies, while significant losers include CalAmp, FOXO Technologies, and Lattice Semiconductor.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 4:31 pm

MRVL

Whales have shown a bullish stance on Marvell Tech (NASDAQ:MRVL) with significant options activity. 51% of trades were bullish, targeting a price range of $50 to $85. Analysts have mixed ratings, with price targets ranging from $77 to $95.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 4:30 pm

AFMD

Affimed shares were halted on a circuit breaker due to a significant upward movement, with the stock now up by 82.1%.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 4:30 pm

Recent options activity for Verizon Communications (NYSE:VZ) shows a predominantly bearish sentiment among large investors, with 81% of trades being bearish. The price range targeted by these trades is between $38.0 and $46.0. The stock is currently priced at $40.95, down 0.49%, with an RSI indicating it may be approaching overbought territory. An analyst from Tigress Financial maintains a Buy rating with a target price of $52.0.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 4:30 pm